Patient perspectives when switching from Cosopt&reg; (dorzolamide-timolol) to Azarga&trade; (brinzolamide-timolol) for glaucoma requiring multiple drug therapy

Graham Anthony Auger, Mathew Raynor, Simon LongstaffOphthalmology Department, Royal Hallamshire Hospital, Sheffield, South Yorkshire, United KingdomBackground: This study aimed to determine the impact of switching patients requiring multiple drug treatment from the dorzolamide-timolol fixed combinat...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Auger GA, Raynor M, Longstaff S
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/ce063d03e5b740d8a156a13fe9af5b82
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Patient perspectives when switching from Cosopt&amp;reg; (dorzolamide-timolol) to Azarga&amp;trade; (brinzolamide-timolol) for glaucoma requiring multiple drug therapy

Ejemplares similares

Patient perspectives when switching from Cosopt® (dorzolamide-timolol) to Azarga™ (brinzolamide-timolol) for glaucoma requiring multiple drug therapy